UMC Health System Implements Retia Medical’s Argos Cardiac Output Monitors Across Multiple ICUs
VALHALLA, N.Y., March 16, 2021 (GLOBE NEWSWIRE) -- Retia Medical announced today the successful installation of its Argos Cardiac Output...
Year: 2021
Rapid Micro Biosystems Raises $81M to Continue Global Expansion of Automated Pharmaceutical QC Platform to Improve Data Integrity and Safety in Biologics, Vaccines, and Cell & Gene Therapy Manufacturing
LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc., the leading provider of data integrity and automation...
Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch
--Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Optimi Health...
Pure Extracts Orders First Shipment of Functional Mushrooms for e-Commerce Store
VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
WESTLAKE VILLAGE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that on March 15, 2021 it issued...
CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases
MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD
Medical cannabis provider aims to accelerate research efforts throughout North AmericaTORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Canada’s leading provider...
Chiesi USA Announces Sponsorship of ASHP Foundation’s Pharmacy Leadership Scholars Program
Program advances research in diversity, equity and inclusion in healthcareCARY, N.C., March 16, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee),...
Advaxis Reports First Quarter Ended January 31, 2021 Financial Results and Provides a Business Update
Continued enrollment in expanded ADXS-503 HOT program in NSCLC to explore potential to enhance and/or restore sensitivity to checkpoint inhibitors...
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a...
Arch Biopartners Receives Health Canada Authorization to Amend Phase II Trial Protocol for LSALT Peptide
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado
DENVER, CO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
The two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in...
BrightInsight and AstraZeneca Collaborate to Enhance Disease Management
BrightInsight Accelerates Time to Market for the AstraZeneca AMAZE Disease Management Platform Within a Regulatory-Compliant Environment BrightInsight and AstraZeneca Collaborate...
Better Choice Announces Formation of Strategic Advisory Committee to Review Potential Strategic Opportunities
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice” or the “Company”), an animal...
Skye Bioscience’s Cannabinoid-Derived Drug Candidate, THCVHS, Demonstrates No Eye Irritation in Preclinical Assessment
San Diego, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA Nephropathy
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First...
IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)...
Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program
SAFEbody technology enables precision masking of antibodies for enhanced safetySAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) --...